Literature DB >> 1786629

Genes associated with tumor suppression and growth control in the human nervous system.

B R Seizinger1.   

Abstract

Cancer, the uncontrolled proliferation of a population of somatic cells, is fundamentally a genetic disorder. Although the specific array of genetic changes causing individual tumor types remains largely obscure, the past two decades have witnessed a tremendous increase in our understanding of the specific genes regulating cell differentiation, proliferation, and senescence. There appear to be two distinct fundamental genetic mechanisms of tumorigenesis. One mechanism is associated with the activation of growth-promoting factors such as proto-oncogenes. Alternatively, tumor formation may be induced as the result of the loss or inactivation of genes which normally regulate or suppress cell growth. These genes have been termed 'tumor suppressor' genes or 'anti-oncogenes'. This review focuses on the role of 'tumor suppressor' genes in tumor formation and growth control of the human nervous system.

Entities:  

Mesh:

Year:  1991        PMID: 1786629     DOI: 10.1007/bf00554790

Source DB:  PubMed          Journal:  Cancer Metastasis Rev        ISSN: 0167-7659            Impact factor:   9.264


  50 in total

Review 1.  Retinoblastoma and the progression of tumor genetics.

Authors:  M F Hansen; W K Cavenee
Journal:  Trends Genet       Date:  1988-05       Impact factor: 11.639

2.  SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene.

Authors:  J A DeCaprio; J W Ludlow; J Figge; J Y Shew; C M Huang; W H Lee; E Marsilio; E Paucha; D M Livingston
Journal:  Cell       Date:  1988-07-15       Impact factor: 41.582

Review 3.  Proto-oncogenes in the nervous system.

Authors:  M R Hanley
Journal:  Neuron       Date:  1988-05       Impact factor: 17.173

4.  Rearrangements of the cellular p53 gene in erythroleukaemic cells transformed by Friend virus.

Authors:  M Mowat; A Cheng; N Kimura; A Bernstein; S Benchimol
Journal:  Nature       Date:  1985 Apr 18-24       Impact factor: 49.962

5.  Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome.

Authors:  S Srivastava; Z Q Zou; K Pirollo; W Blattner; E H Chang
Journal:  Nature       Date:  1990 Dec 20-27       Impact factor: 49.962

6.  Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients.

Authors:  M R Wallace; D A Marchuk; L B Andersen; R Letcher; H M Odeh; A M Saulino; J W Fountain; A Brereton; J Nicholson; A L Mitchell
Journal:  Science       Date:  1990-07-13       Impact factor: 47.728

7.  Common pathogenetic mechanism for three tumor types in bilateral acoustic neurofibromatosis.

Authors:  B R Seizinger; G Rouleau; L J Ozelius; A H Lane; P St George-Hyslop; S Huson; J F Gusella; R L Martuza
Journal:  Science       Date:  1987-04-17       Impact factor: 47.728

8.  Mutation and cancer: statistical study of retinoblastoma.

Authors:  A G Knudson
Journal:  Proc Natl Acad Sci U S A       Date:  1971-04       Impact factor: 11.205

9.  Loss of heterozygosity on chromosomes 3, 13, and 17 in small-cell carcinoma and on chromosome 3 in adenocarcinoma of the lung.

Authors:  J Yokota; M Wada; Y Shimosato; M Terada; T Sugimura
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

10.  Suppression of the neoplastic phenotype by replacement of the RB gene in human cancer cells.

Authors:  H J Huang; J K Yee; J Y Shew; P L Chen; R Bookstein; T Friedmann; E Y Lee; W H Lee
Journal:  Science       Date:  1988-12-16       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.